Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluating Walking Kinetic of Children Who Suffer Central Nervous System (CNS) Damage

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Sheba Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Dr. Ofer Keren, Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01158027
First received: July 4, 2010
Last updated: October 17, 2011
Last verified: October 2011
  Purpose

The goal of the present study is to look at the effect of changing walking parameters on the dynamic walking characteristics among children post severe traumatic brain injury, and typically developed controls.


Condition Intervention
Walking Performance
Other: gait evaluation

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Evaluating Walking Kinetic of Children Who Suffer Central Nervous System (CNS)

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 30
Study Start Date: October 2011
Groups/Cohorts Assigned Interventions
children Other: gait evaluation
The children will asked to walk under different conditions: (1) walking at a self-selected speed faster and slower on the GAITRite® system and on a treadmill and while listening and to a metronomeQuoting.

  Eligibility

Ages Eligible for Study:   8 Years to 13 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Fifteen children post-TBI and fifteen typically control.

Criteria

Inclusion Criteria:

  1. post-severe closed head injury (Glasgow Coma Scale [GCS] score at admission to emergency room of ≤8) [Kathryn 2008].
  2. at least one year post trauma.
  3. ages 7 to 13 years.
  4. independent ambulation (foot orthoses permitted).

Exclusion Criteria:

  1. had received botulinum toxin for spasticity management or had undergone orthopedic surgery in the past six months.
  2. unable to follow simple instructions.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Dr. Ofer Keren, MD, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT01158027     History of Changes
Other Study ID Numbers: SHEBA-10-7999-OK-CTIL
Study First Received: July 4, 2010
Last Updated: October 17, 2011
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

ClinicalTrials.gov processed this record on November 24, 2014